Journal September 25, 2026 5 min read

Which peptides are studied in relation to caloric restriction?

A research-supply overview of the peptides and related compounds examined alongside caloric restriction in laboratory and clinical studies, with notes on model systems and evidence limits.

peptides-pro Editorial

Direct answer

In the research literature, the compounds most often studied in relation to caloric restriction are not a single peptide class but a set of interventions that overlap with the metabolic and cellular pathways caloric restriction engages. These include the incretin-based peptides used in metabolic research, the senolytic and senomorphic agents examined for their effects on ageing hallmarks, and multi-component nutritional formulations designed to preserve lean mass during energy restriction. The evidence base is mixed: some work is in rodents, some is in vitro, and some is early-phase human study.

The pathway most consistently implicated is the nutrient-sensing network centred on mTOR and its downstream targets, alongside mitochondrial quality-control mechanisms and cellular senescence programmes. Caloric restriction is used in these studies as a comparator, a co-intervention, or a physiological state against which a compound's effects are measured.

Research Studies

Incretin-based peptides and lean mass during weight loss

Incretin-based therapies have changed the treatment landscape for type 2 diabetes and obesity by producing weight loss of a magnitude previously associated only with intensive caloric restriction or bariatric surgery. This has shifted clinical attention from the quantity of weight lost to the composition of that loss, particularly the loss of skeletal muscle. A review of this area reports that the sarcopenia challenge associated with incretin-based therapies is now a central concern in the field [9].

Multi-component nutritional formula and muscle maintenance under caloric restriction

A registered study is investigating a multi-component formulation, Redefine, used as an adjunct to a well-established caloric restriction regimen in adults. The primary goal is to demonstrate safety and tolerability, with muscle loss during caloric restriction identified as a significant concern for metabolic health and physical function. The study notes that caloric restriction is known to result in unintended loss of skeletal muscle mass, which may negatively affect physical function [6].

Probiotic preparation and weight regain after caloric restriction

A separate registered study is evaluating a probiotic preparation in weight cyclers. The background states that weight regain is common after dietary control due to metabolic adaptations that follow caloric restriction, and that gut microbiota play a critical role in weight management. The study aims to assess whether probiotics reduce weight regain by modulating appetite and metabolism, with prior studies suggesting enhanced satiety and reduced appetite [7].

Low-dose tamoxifen, intermittent caloric restriction and SHBG

A clinical trial in women at increased risk of breast cancer is comparing low-dose tamoxifen with a lifestyle intervention, with or without intermittent caloric restriction, over six months. The primary aim is to determine whether low-dose tamoxifen increases circulating levels of sex hormone binding globulin (SHBG) more than the lifestyle intervention. Circulating SHBG levels are reported to be significantly associated with a decreased risk of breast cancer [8].

Autophagy, exercise and diet in depression

A registered study is examining how lifestyle factors including physical activity and diet-related processes influence autophagy, a cellular process that removes damaged components and maintains healthy function. Autophagy is influenced by energy availability and may be affected by behaviours such as physical exercise and caloric restriction. The study is set in the context of depression, a leading cause of disability for which many patients do not fully recover with current treatments [1].

Food insecurity, gut signal sensitivity and appetitive behaviour in female rats

In adolescent female rats, a four-week protocol assigned animals to ad libitum chow, 90% caloric restriction, or unpredictable quantity and timing of food access. The study investigated whether food insecurity causes dysregulated feeding behaviours, specifically impaired gut signal sensitivity and enhanced cue-driven appetitive responses. After the intervention, rats were returned to ad libitum chow [2].

Age-associated immune and molecular alterations in colonic mucosa

A spatial proteomics pilot analysis of ageing murine gut mucosa reported a network of interdependent age-related changes. These included accumulation of senescent T cells near the epithelial layer, increased expression of ribosomal protein S6 kinase (an mTOR target), and upregulation of the glycolytic enzyme GAPDH [3].

Short-term performance assay for longevity interventions in mice

An eight-week mouse study profiled five candidate anti-ageing treatments: 17α-estradiol, rapamycin plus Smer28, berberine plus resveratrol, sildenafil, and pinealon. The protocol longitudinally monitored body weight, temperature, food intake, and performance, with the aim of rapidly assessing both functional benefits and early toxicity of longevity interventions [4].

Senolytics, senomorphics and ageing hallmarks

A review of therapeutic strategies for ageing and ageing-associated diseases describes three approaches: senolytics, which eliminate senescent cells (for example, dasatinib plus quercetin); senomorphics, which inhibit the senescence-associated secretory phenotype (for example, rapamycin); and a third category targeting related mechanisms. The review frames these as interventions that modulate core ageing mechanisms including cellular senescence, metabolic dysfunction, epigenetic alterations, and mitochondrial impairment [5].

Caloric restriction in an experimental model of systemic lupus erythematosus

In an experimental model of systemic lupus erythematosus, caloric restriction decreased autoimmune disease activity and lowered blood pressure. The background notes that obesity is associated with greater SLE disease activity and is a significant modifiable risk factor for hypertension [11].

Mitochondrial quality control in human ageing and longevity

Mitochondrial quality-control mechanisms continuously monitor organelle integrity and function, repairing or eliminating damaged mitochondria and replacing them with newly formed ones. These mechanisms are central to cellular metabolism and to processes including inflammation, stress response, cell death, and signalling [12].

Mitochondrial research in diabetic nephropathy

A bibliometric analysis mapped global mitochondrial research in diabetic nephropathy from 2016 to 2025, providing a landscape view of publication trends in this area [10].

If you are reading this for personal health reasons

The compounds and formulations described here are sold for laboratory research use only. We do not provide dosing, medical guidance, or recommendations for personal use. Anyone considering a compound for themselves should speak to a licensed clinician.